Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Buy Sophos Group (SOPH) by UBS
- Underperform Convatec Group (CTEC) by Credit Suisse
- Underperform Cairn Energy (CNE) by Jefferies
- Neutral Lookers (LOOK) by JP Morgan
- Hold South32 Limited (DI) (S32) by HSBC
- Buy Kaz Minerals (KAZ) by HSBC
- Equal Weight BT Group (BT.A) by Morgan Stanley
- Buy WPP (WPP) by UBS
- Buy Yellow Cake (YCA) by Berenberg
- Hold Direct Line Insurance Group (DLG) by Berenberg
- Sell Admiral Group (ADM) by Berenberg
- Buy DCC (DCC) by Berenberg
- Buy Sabre Insurance Group (SBRE) by Berenberg
- Buy Hastings Group Holdings (HSTG) by Berenberg
- Hold Victrex plc (VCT) by Peel Hunt
- Buy Rathbone Brothers (RAT) by Peel Hunt
- Buy Persimmon (PSN) by Mark Howitt in The Motley Fool
- Hold Barratt Developments (BDEV) by Mark Howitt in The Motley Fool
- Overweight Pearson (PSON) by JP Morgan
- Overweight Sophos Group (SOPH) by JP Morgan
AstraZeneca (AZN)
Health Care Sector
-
Latest quote
6,331.00p (mid)
-
Current Change (%)
0.60%
-
Price
Bid: 6,360.00p
Offer: 6,362.00p
-
Today
High: 6,375.00p
Low: 6,295.00p
-
This year
High: 6,602.00p
Low: 5,325.00p
-
Information
Volume: 726,899
Market Cap: £82999.41M
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca RNS Feed
| Title | Release date |
|---|---|
| Update on US regulatory decision for Farxiga | 07:00 - July 15, 2019 |
| Imfinzi granted US Orphan Drug Designation for | 07:00 - July 12, 2019 |
| Total Voting Rights | 15:00 - July 1, 2019 |
| Fasenra receives positive EU CHMP opinion for self | 07:00 - July 1, 2019 |
| Forxiga receives positive EU CHMP opinion for | 07:00 - July 1, 2019 |
| Bevespi Aerosphere approved by the Japanese | 07:00 - June 19, 2019 |
| Lynparza approved in Japan for 1st-line | 07:00 - June 19, 2019 |
| Breztri Aerosphere (PT010) approved in Japan for | 07:00 - June 19, 2019 |
| Lynparza approved in the EU for 1st-line | 07:00 - June 18, 2019 |
| Calquence significantly prolonged the time patient | 07:00 - June 17, 2019 |
| Publication of a Prospectus | 16:45 - June 12, 2019 |
| Calquence Phase III ELEVATE-TN trial met primary | 07:00 - June 6, 2019 |
| Hardman & Co Research: AstraZeneca: Where has all the cash gone? | 12:36 - June 5, 2019 |
| Total Voting Rights | 15:00 - June 3, 2019 |
| Block listing Interim Review | 15:00 - June 3, 2019 |
NOTE: This is based on 251 open tips for this company
